Chief Operations Officer van Walsem will lead commercial scale-up of Lygos' specialty biochemicals, starting with the Bio-Malonate™ Platform. BERKELEY, July 25, 2017 (GLOBE NEWSWIRE) -- Lygos, a leading innovator in developing sustainable high-value specialty chemicals, today announced that industry veteran [...]
St. Paul, Minn. and New York, NY, July 19, 2017 – Cellectis S.A. and Calyxt, Inc. announced today the pricing of Calyxt’s initial public offering of 7,000,000 shares of its common stock at the initial public offering price of $8.00 per [...]
July 24, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention [...]
SHENZHEN, China, July 14, 2017 — BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. BGI Genomics has been listed on [...]
London, UK, 21st July 2017 / Sciad Newswire / A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and [...]
07.20.2017 - Stella McCartney continues the brand’s dedication to fashion eco innovation with the announcement of a new partnership with Bolt Threads, a Bay Area-based biotechnology company creating the next generation of advanced materials. This new collaboration will push boundaries in [...]
